PhRMA official discusses legislative priorities, lessons from the pandemic

The Pharmaceutical Research and Manufacturers of America (PhRMA) recently published a wish list of changes that it wants policymakers and regulators to consider to prepare for the next pandemic. A top official at the industry group spoke with Focus about these goals and what it is doing to further them.